Press Release

-1

archive,category,category-press-release,category-96,bridge-core-2.5.8,ajax_fade,page_not_loaded,,qode-theme-ver-24.3,qode-theme-bridge,disabled_footer_top,qode_header_in_grid,wpb-js-composer js-comp-ver-6.4.2,vc_responsive

Press Release

Posted at 16 Feb, 19:16h in Press Release by adialpharma 0 Comments

0 Likes

Adial Pharmaceuticals Announces Closing of $10 Million Financing

Posted at 11 Feb, 19:15h in Press Release by adialpharma 0 Comments

0 Likes

Adial Pharmaceuticals Announces Pricing of $10 Million Registered Direct Offering

Posted at 09 Feb, 19:14h in Press Release by adialpharma 0 Comments

0 Likes

Adial Pharmaceuticals Announces Positive In Vivo Data for Purnovate’s PNV-5032 as a Potential Treatment for Asthma

Posted at 06 Jul, 15:51h in Press Release by adialpharma 0 Comments

0 Likes

The Phase 3 ONWARD™ Trial Meets its Screening Target and Nears Enrollment Completion

Posted at 28 Jun, 16:21h in Press Release by adialpharma 0 Comments

0 Likes

Adial Joins Russell Microcap® Index

Posted at 24 Jun, 16:22h in Press Release by adialpharma 0 Comments

0 Likes

Adial Pharmaceuticals Provides Regulatory and Development Update

Posted at 22 Jun, 16:23h in Press Release by adialpharma 0 Comments

0 Likes

Adial Pharmaceuticals Plans to Enter Genetic Testing Market Following Allowance of U.S. Patent for Genetic Diagnostic Test

Posted at 07 Jun, 19:32h in Press Release by adialpharma 0 Comments

0 Likes

Adial Pharmaceuticals Comments on Article in ‘The Atlantic,’ Highlighting the Second Pandemic of Addiction

Posted at 03 Jun, 19:33h in Press Release by adialpharma 0 Comments

0 Likes

Adial Announces Funding of Management-Led $2,100,000 Above Market Private Placement at $3.00 Per Share

Posted at 18 May, 19:33h in Press Release by adialpharma 0 Comments

0 Likes

Adial Pharmaceuticals Featured on Multiple News Broadcasts Nationwide Regarding the Second Pandemic of Alcohol Use Disorder